Haitian Gui , Tao Su , Xinhua Jiang , Li Li , Lang Xiong , Ji Zhou , Zhiyong Pang
{"title":"FS-YOLOv9:基于频率和空间特征的实时乳腺癌检测 YOLOv9。","authors":"Haitian Gui , Tao Su , Xinhua Jiang , Li Li , Lang Xiong , Ji Zhou , Zhiyong Pang","doi":"10.1016/j.acra.2024.09.048","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale and Objectives</h3><div>Breast cancer screening is critical for reducing mortality rates. YOLOv9, a new real-time object-detection model, is ideal for cancer screening. A customized YOLOv9 model with enhancements for detecting breast cancer on the basis of species and morphological diversity has potential clinical significance.</div></div><div><h3>Materials and Methods</h3><div>The internal dataset consisted of 687 cases split 3:1 for cross-validation. Additionally, 98 cases from external datasets were used for testing. We developed an FS-YOLOv9 model customized for breast cancer detection that incorporated an extra max-pooling layer before the Conv1 of the Adown to enhance high-brightness features. The Adown of the P3 in the backbone was replaced with a high-frequency Haar wavelet convolution kernel, which ignored the low-frequency components during down-sampling to enhance morphology and texture features. The reliability and robustness of our model was determined by measuring the F1 score, the area under curve of free-response receiver operating characteristic (FAUC), mean average precision (mAP), recall, and precision, and comparing them with the findings for the official YOLOv9, YOLOv8, YOLOv5 models.</div></div><div><h3>Results</h3><div>In comparison with the official YOLOv9 model, FS-YOLOv9 showed a higher average F1 score (0.700 vs. 0.669), FAUC (0.695 vs. 0.662), and mAP50 (0.713 vs. 0.679) in the internal dataset; in the external testing dataset, the FS-YOLOv9 improved the average F1 score, FAUC, and mAP50 by 4.58%, 5.78%, and 4.41% respectively.</div></div><div><h3>Conclusion</h3><div>Our FS-YOLOv9 model showed significantly improved performance in detecting breast cancer, making it more practical for high-risk breast cancer diagnosis.</div></div>","PeriodicalId":50928,"journal":{"name":"Academic Radiology","volume":"32 3","pages":"Pages 1228-1240"},"PeriodicalIF":3.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"FS-YOLOv9: A Frequency and Spatial Feature-Based YOLOv9 for Real-time Breast Cancer Detection\",\"authors\":\"Haitian Gui , Tao Su , Xinhua Jiang , Li Li , Lang Xiong , Ji Zhou , Zhiyong Pang\",\"doi\":\"10.1016/j.acra.2024.09.048\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Rationale and Objectives</h3><div>Breast cancer screening is critical for reducing mortality rates. YOLOv9, a new real-time object-detection model, is ideal for cancer screening. A customized YOLOv9 model with enhancements for detecting breast cancer on the basis of species and morphological diversity has potential clinical significance.</div></div><div><h3>Materials and Methods</h3><div>The internal dataset consisted of 687 cases split 3:1 for cross-validation. Additionally, 98 cases from external datasets were used for testing. We developed an FS-YOLOv9 model customized for breast cancer detection that incorporated an extra max-pooling layer before the Conv1 of the Adown to enhance high-brightness features. The Adown of the P3 in the backbone was replaced with a high-frequency Haar wavelet convolution kernel, which ignored the low-frequency components during down-sampling to enhance morphology and texture features. The reliability and robustness of our model was determined by measuring the F1 score, the area under curve of free-response receiver operating characteristic (FAUC), mean average precision (mAP), recall, and precision, and comparing them with the findings for the official YOLOv9, YOLOv8, YOLOv5 models.</div></div><div><h3>Results</h3><div>In comparison with the official YOLOv9 model, FS-YOLOv9 showed a higher average F1 score (0.700 vs. 0.669), FAUC (0.695 vs. 0.662), and mAP50 (0.713 vs. 0.679) in the internal dataset; in the external testing dataset, the FS-YOLOv9 improved the average F1 score, FAUC, and mAP50 by 4.58%, 5.78%, and 4.41% respectively.</div></div><div><h3>Conclusion</h3><div>Our FS-YOLOv9 model showed significantly improved performance in detecting breast cancer, making it more practical for high-risk breast cancer diagnosis.</div></div>\",\"PeriodicalId\":50928,\"journal\":{\"name\":\"Academic Radiology\",\"volume\":\"32 3\",\"pages\":\"Pages 1228-1240\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Academic Radiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1076633224006974\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Academic Radiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1076633224006974","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
摘要
理由和目标:乳腺癌筛查对于降低死亡率至关重要。新型实时物体检测模型 YOLOv9 是癌症筛查的理想选择。定制的 YOLOv9 模型在物种和形态多样性的基础上增强了检测乳腺癌的功能,具有潜在的临床意义:内部数据集由 687 个病例组成,以 3:1 的比例进行交叉验证。此外,我们还使用了外部数据集中的 98 个病例进行测试。我们开发了一个专为乳腺癌检测定制的 FS-YOLOv9 模型,该模型在 Adown 的 Conv1 之前加入了一个额外的最大池化层,以增强高亮度特征。骨干 P3 的 Adown 由高频 Haar 小波卷积核代替,在下采样过程中忽略了低频成分,以增强形态和纹理特征。通过测量 F1 分数、自由响应接收器操作特征曲线下面积(FAUC)、平均精度(mAP)、召回率和精度,并与官方 YOLOv9、YOLOv8 和 YOLOv5 模型的结果进行比较,确定了我们的模型的可靠性和鲁棒性:与官方 YOLOv9 模型相比,FS-YOLOv9 在内部数据集中的平均 F1 得分(0.700 vs. 0.669)、FAUC(0.695 vs. 0.662)和 mAP50(0.713 vs. 0.679)更高;在外部测试数据集中,FS-YOLOv9 的平均 F1 得分、FAUC 和 mAP50 分别提高了 4.58%、5.78% 和 4.41%:我们的 FS-YOLOv9 模型在检测乳腺癌方面的性能有了显著提高,使其更适用于高危乳腺癌诊断。
FS-YOLOv9: A Frequency and Spatial Feature-Based YOLOv9 for Real-time Breast Cancer Detection
Rationale and Objectives
Breast cancer screening is critical for reducing mortality rates. YOLOv9, a new real-time object-detection model, is ideal for cancer screening. A customized YOLOv9 model with enhancements for detecting breast cancer on the basis of species and morphological diversity has potential clinical significance.
Materials and Methods
The internal dataset consisted of 687 cases split 3:1 for cross-validation. Additionally, 98 cases from external datasets were used for testing. We developed an FS-YOLOv9 model customized for breast cancer detection that incorporated an extra max-pooling layer before the Conv1 of the Adown to enhance high-brightness features. The Adown of the P3 in the backbone was replaced with a high-frequency Haar wavelet convolution kernel, which ignored the low-frequency components during down-sampling to enhance morphology and texture features. The reliability and robustness of our model was determined by measuring the F1 score, the area under curve of free-response receiver operating characteristic (FAUC), mean average precision (mAP), recall, and precision, and comparing them with the findings for the official YOLOv9, YOLOv8, YOLOv5 models.
Results
In comparison with the official YOLOv9 model, FS-YOLOv9 showed a higher average F1 score (0.700 vs. 0.669), FAUC (0.695 vs. 0.662), and mAP50 (0.713 vs. 0.679) in the internal dataset; in the external testing dataset, the FS-YOLOv9 improved the average F1 score, FAUC, and mAP50 by 4.58%, 5.78%, and 4.41% respectively.
Conclusion
Our FS-YOLOv9 model showed significantly improved performance in detecting breast cancer, making it more practical for high-risk breast cancer diagnosis.
期刊介绍:
Academic Radiology publishes original reports of clinical and laboratory investigations in diagnostic imaging, the diagnostic use of radioactive isotopes, computed tomography, positron emission tomography, magnetic resonance imaging, ultrasound, digital subtraction angiography, image-guided interventions and related techniques. It also includes brief technical reports describing original observations, techniques, and instrumental developments; state-of-the-art reports on clinical issues, new technology and other topics of current medical importance; meta-analyses; scientific studies and opinions on radiologic education; and letters to the Editor.